Abstract
The present disclosure relates to novel crystalline forms of 2-{3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy}-N-(propan-2-yl) acetamide mesylate and their processes for the preparations thereof. 2-{3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy}-N-(propan-2-yl) acetamide represented by the following structural formula-1, which is referred to as Belumosudil.
Formula-1.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan, Sajja Eswaraiah, Vijayavitthal T. Mathad, Sagyam Rajeshwar Reddy, Keshavareddy Navin Kumar Reddy, Saladi Venkata Narasayya, Kammari Balraju, Kootikanti Krishnaiah and Manepalli Ushasri, "Novel crystalline forms of 2-{3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl] phenoxy}-N-(propan-2-yl) acetamide mesylate", Technical Disclosure Commons, (December 19, 2023)
https://www.tdcommons.org/dpubs_series/6511